Circular Economy Brazil: Technology Adoption Risks
Brazil is advancing its environmental goals, creating potential demand for innovative waste and resource management solutions. This basket provides exposure to US and EU-listed companies that supply the technologies and materials essential for building a circular system.
Your Basket's Financial Footprint
Market capitalisation breakdown and concise investor takeaways for the basket.
- Large-cap dominance generally implies lower volatility and closer tracking to broad-market performance, reducing idiosyncratic risk.
- Use this basket as a core, stabilising holding rather than a speculative or short-term growth allocation.
- Expect steady, long-term appreciation; don’t rely on rapid, explosive gains from this large-cap weighted basket.
WM: $80.48B
BALL: $12.79B
AMCR: $18.24B
- Other
About This Group of Stocks
Our Expert Thinking
Brazil's commitment to environmental sustainability is creating massive opportunities in the circular economy. We've identified companies that are essential to this transformation - from sustainable packaging innovators to advanced recycling technology providers. These firms are positioned to benefit as Brazil shifts from wasteful linear systems to regenerative circular models that reuse and repurpose materials.
What You Need to Know
This group focuses on the infrastructure and technology needed to build circular systems in Brazil. The companies span different roles - some create sustainable packaging materials like aluminium and glass, others develop cutting-edge recycling technology, and some manage large-scale waste processing. Together, they represent the key enablers of Brazil's circular economy transition.
Why These Stocks
These companies were handpicked because they're either global leaders with significant Brazilian operations or provide essential technologies that Brazil needs for its circular economy goals. Each firm plays a critical role in replacing the traditional 'take-make-dispose' model with sustainable alternatives that could transform everything from urban waste management to industrial manufacturing across the country.
Why You'll Want to Watch These Stocks
Brazil's Green Revolution
As Brazil intensifies its environmental commitments, companies providing circular economy solutions are positioned to benefit from massive infrastructure investments and policy support.
Circular Systems Taking Off
The shift from wasteful linear models to regenerative circular systems represents a fundamental change in how materials flow through the economy, creating new revenue streams.
Global Leaders, Local Impact
These aren't just any companies - they're industry leaders with the technology, scale, and expertise to transform Brazil's approach to waste and resource management.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.